Keiya Ozawa
- Genetics top 0.2%
- Virus-based gene therapy research 99
- Mesenchymal stem cell research 24
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 30
- Acute Myeloid Leukemia Research 29
- Genetics top 0.5%
- Virus-based gene therapy research 99
- Mesenchymal stem cell research 24
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery 46
- Viral Infectious Diseases and Gene Expression in Insects 30
- CRISPR and Genetic Engineering 28
- Oncology top 1%
- CAR-T cell therapy research 30
- Co-authors
- Hiroaki MizukamiAkihiro KumeMasashi UrabeTadashi NagaiTakashi OkadaKazuo MuroiMichel SadelainCynthia E. Dunbar
- Cited by
- GeneticsHematology
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (4 papers)Nucleic Acids Research (1 paper)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Keiya Ozawa
337 papers receiving 11.8k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Genetics 2.5k
- Hematology 1.9k
- Genetics 2.8k
- Molecular Biology 6.3k
- Oncology 2.1k
Countries citing papers authored by Keiya Ozawa
This map shows the geographic impact of Keiya Ozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiya Ozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiya Ozawa more than expected).
Fields of papers citing papers by Keiya Ozawa
This network shows the impact of papers produced by Keiya Ozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiya Ozawa. The network helps show where Keiya Ozawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keiya Ozawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2019 | 67 | |
| 3 | Gene therapy comes of agebreakdown → | 2018 | 993 |
| 4 | 2013 | 62 | |
| 5 | 2012 | 72 | |
| 6 | 2010 | 6 | |
| 7 | 2009 | 4 | |
| 8 | 2008 | 53 | |
| 9 | 2007 | 4 | |
| 10 | 2006 | 15 | |
| 11 | 2006 | 19 | |
| 12 | Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura-The associateion between the activity of Helicobacter pylori and platelet recovery-:—The associateion between the activity of Helicobacter pylori and platelet recovery— | 2004 | 1 |
| 13 | Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. | 2003 | 59 |
| 14 | 2002 | 3 | |
| 15 | 2002 | 34 | |
| 16 | 1999 | 26 | |
| 17 | 1999 | 77 | |
| 18 | 1998 | 102 | |
| 19 | 1998 | 11 | |
| 20 | 1024 TRANSFER OF ENDOTHELIAL CONSTITUTIVE NITRIC OXIDE SYNTHASE GENE INTO VASCULAR STRUCTURE USING ADENO-ASSOCIATED VIRUS VECTORS | 1997 | 1 |
About Keiya Ozawa
Keiya Ozawa is a scholar working on Hematology, Genetics and Genetics, having authored 339 papers that have together received 12.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (99 papers), RNA Interference and Gene Delivery (46 papers), CAR-T cell therapy research (30 papers), Viral Infectious Diseases and Gene Expression in Insects (30 papers), Hematopoietic Stem Cell Transplantation (30 papers), Acute Myeloid Leukemia Research (29 papers), CRISPR and Genetic Engineering (28 papers) and Mesenchymal stem cell research (24 papers). The work is most often cited by research in Genetics (2.5k citations), Hematology (1.9k citations) and Genetics (2.8k citations). Keiya Ozawa has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Hiroaki Mizukami, Akihiro Kume, Masashi Urabe, Tadashi Nagai, Takashi Okada, Kazuo Muroi, Michel Sadelain, Cynthia E. Dunbar, Donald B. Kohn and Katherine A. High. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.